XML 164 R145.htm IDEA: XBRL DOCUMENT v3.10.0.1
Employee Compensation and Benefit Plans Schedule of Stock Unit Activity (Details) - $ / shares
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]      
Unvested at beginning of year (in shares) 2,753,918 [1],[2] 2,752,054 [1],[2] 835,730
Unvested at beginning of year (in dollar per share) $ 3.69 [1],[2] $ 3.91 [1],[2] $ 10.00
Granted (in shares) 1,809,373 971,761 2,184,100
Granted (in dollar per share) $ 3.57 $ 2.56 $ 2.19
Vested (in shares) [3],[4] (796,856) (896,272) (26,666)
Vested (in dollar per share) [3],[4] $ 2.78 $ 3.26 $ 32.56
Forfeited/Canceled (in shares) (819,635) (73,625) (241,110)
Forfeited/Canceled (in dollar per share) $ 4.57 $ 2.20 $ 6.17
Unvested at end of year (in shares) [1],[2] 2,946,800 2,753,918 2,752,054
Unvested at end of year (in dollar per share) [1],[2] $ 3.75 $ 3.69 $ 3.91
[1] The total fair value of the stock units that vested during 2018, 2017 and 2016, based on grant-date fair value, was $2.2 million, $2.9 million and $0.9 million, respectively.
[2] The total intrinsic value of stock units vested, which is defined as the market value of the stock on the date of vesting, was $3.3 million, $4.6 million and $0.1 million for 2018, 2017 and 2016, respectively.
[3] Stock units granted in 2018 include 983,010 units granted to Ocwen’s current Chief Executive Officer on the effective date of his employment, which was the closing date of the PHH acquisition.
[4] Upon the resignation of Ocwen’s former Chief Executive Officer on June 30, 2018, 377,525 unvested stock units which would have been forfeited immediately were modified to allow continued vesting in accordance with the original terms. This had the equivalent effect of canceling the original award and granting a new award.